AMZN
Amazon.com, Inc.
AMZN has the edge over AOUT overall, supported by lower modeled downside and stronger valuation.
AOUT
American Outdoor Brands, Inc.
AOUT's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
AOUT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
AOUT's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
AOUT PE Valuation
AOUT has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
AOUT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for AOUT, with profitability improving. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over AOUT on earnings quality, reporting a profit while its opponent remains loss making.
AOUT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.60 | — |
| Q3 2026 | -$0.31 | +$0.06 |
| Q2 2026 | -$0.73 | -$0.72 |
| Q1 2026 | -$0.78 | -$0.44 |
| Q4 2025 | -$0.45 | +$0.13 |
| Q3 2025 | -$0.37 | +$0.44 |
| Q2 2025 | -$0.01 | +$0.93 |
| Q1 2025 | -$0.34 | +$0.49 |
| Q4 2024 | -$0.58 | +$0.23 |
AOUT is still losing money, but far less than before: $0.31 per share over the past year, against $6.93 at its worst in early 2020.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over AOUT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over AOUT on profitability, with a higher operating margin.
AOUT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $37.3M | +25% |
| Q2 2026 | $47.1M | -24% |
| Q1 2026 | $56.6M | -3.3% |
| Q4 2025 | $57.2M | -5% |
| Q3 2025 | $29.7M | -29% |
| Q2 2025 | $61.9M | +34% |
| Q1 2025 | $58.5M | +9.5% |
| Q4 2024 | $60.2M | +4% |
AOUT's revenue is recovering but still below its 2021 peak: $37M last quarter, up 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.7% | +17 points |
| Q2 2026 | -0.8% | +0.8 points |
| Q1 2026 | -6.9% | -7.4 points |
| Q4 2025 | 3.7% | -1.4 points |
| Q3 2025 | -23% | -17 points |
| Q2 2025 | -1.5% | +10 points |
| Q1 2025 | 0.5% | +5.9 points |
| Q4 2024 | 5.1% | +5.1 points |
AOUT's operating margin was −5.7% last quarter, up 17 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
AOUT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $12.9M | +$14.9M |
| Q2 2026 | $11.4M | +58% |
| Q1 2026 | $9M | +114% |
| Q4 2025 | -$14.1M | -$6.1M |
| Q3 2025 | -$2M | +$3.2M |
| Q2 2025 | $7.2M | -49% |
| Q1 2025 | $4.2M | -57% |
| Q4 2024 | -$8M | +$763K |
AOUT has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
AOUT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -37K shares |
| 1 year | -1.3% | -169K shares |
| 3 years | -4.9% | -640K shares |
| 5 years | -12% | -1.8M shares |
| Available history | -9.6% | -1.3M shares |
AOUT has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $508,000 |
| Q1 2026 | $1.4M |
| Q4 2025 | $662,000 |
| Q3 2025 | $2.5M |
| Q2 2025 | $1.2M |
| Q1 2025 | $1.2M |
| Q4 2024 | $1M |
AOUT spent $3M buying back its own shares over the past year, down 57% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AOUT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.5x | Net Cash |
| Q2 2026 | -6.2x | Net Cash |
| Q1 2026 | -3.1x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
AOUT has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
AOUT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 89.4 | Overbought |
AOUT's weekly RSI is 68 (neutral) and its Stochastic is 89 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
AOUT PE vs Consumer Cyclical Sector
| Metric | AOUT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
AOUT has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
AOUT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.5 | 8.3% above |
| 20 week MA | $15.0 | 26% above |
| 50 week MA | $11.5 | 65% above |
| 100 week MA | $11.4 | 67% above |
| 200 week MA | $10.2 | 86% above |
AOUT is in an uptrend: it's above all five of its weekly moving averages, and 86% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
AOUT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.5 | $17.5 | +13% |
| 2021 | $17.5 | $19.0 | +8.6% |
| 2022 | $19.0 | $9.67 | -49% |
| 2023 | $9.67 | $8.40 | -13% |
| 2024 | $8.40 | $14.9 | +78% |
| 2025 | $14.9 | $8.28 | -45% |
| 2026 YTD | $8.28 | $19.0 | +129% |
AOUT has the edge over AMZN on returns for 2026, with the stronger performance.